Progression of Metastatic Pancreatic Cancer
5 意见
administrator
07/30/23
George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
显示更多
脸书评论
没有找到评论